Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review.
Curr Vasc Pharmacol
; 17(5): 515-537, 2019.
Article
em En
| MEDLINE
| ID: mdl-31309820
Palavras-chave
PCSK9 inhibitors; Postprandial hypertriglyceridaemia; anti-obesity drugs; atherosclerotic cardiovascular disease; bariatric surgery; chronic kidney disease; diabetes mellitus; ezetimibe; familial dyslipidaemia; fibrates; lipoprotein apheresis; metabolic syndrome; n-3 fatty acids; nicotinic acid; non-alcoholic fatty liver; oral fat tolerance test; statins; triglycerides.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Triglicerídeos
/
Análise Química do Sangue
/
Doenças Cardiovasculares
/
Hipertrigliceridemia
/
Período Pós-Prandial
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article